On Friday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was -9.33% drop from the session before settling in for the closing price of $3.86. A 52-week range for IRWD has been $0.53 – $5.13.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -47.49%. When this article was written, the company’s average yearly earnings per share was at 1448.53%. With a float of $156.69 million, this company’s outstanding shares have now reached $162.68 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ironwood Pharmaceuticals Inc stocks. The insider ownership of Ironwood Pharmaceuticals Inc is 3.68%, while institutional ownership is 91.66%. The most recent insider transaction that took place on Nov 17 ’25, was worth 19,973. In this transaction Chief Commercial Officer of this company sold 6,016 shares at a rate of $3.32, taking the stock ownership to the 235,264 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Officer proposed sale 6,324 for $3.37, making the entire transaction worth $21,312.
Ironwood Pharmaceuticals Inc (IRWD) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.02 earnings per share (EPS) during the time that was less than consensus figure (set at 0.08) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
You can see what Ironwood Pharmaceuticals Inc (IRWD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.68. Likewise, its price to free cash flow for the trailing twelve months is 8.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.15, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach 0.45 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
The latest stats from [Ironwood Pharmaceuticals Inc, IRWD] show that its last 5-days average volume of 2.55 million was inferior to 2.59 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.73%.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 86.81%, which indicates a significant increase from 73.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.41 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.03, while its 200-day Moving Average is $1.28. Now, the first resistance to watch is $3.82. This is followed by the second major resistance level at $4.14. The third major resistance level sits at $4.35. If the price goes on to break the first support level at $3.29, it is likely to go to the next support level at $3.08. Assuming the price breaks the second support level, the third support level stands at $2.76.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are 162,679K outstanding shares of the company, which has a market capitalization of 569.38 million. As of now, sales total 351,410 K while income totals 880 K. Its latest quarter income was 122,060 K while its last quarter net income were 40,080 K.
